← Back to headlines
Medpace Holdings (MEDP) Benefits from GLP-1 Drug Market Strength
Medpace Holdings (MEDP) has reportedly seen benefits from the strong performance and demand within the GLP-1 drug market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
9h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
11h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
19h ago